Skip to content

Clinical Efficacy and Mechanism of Jiawei Qibai Powder in External Treating Melasma (Spleen Deficiency and Dampness Syndrome)

Clinical Efficacy and Mechanism of Jiawei Qibai Powder in External Treating Melasma (Spleen Deficiency and Dampness Syndrome)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000746
Enrollment
Unknown
Registered
2025-04-14
Start date
2023-04-11
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

control group:On the basis of taking Shen Ling Bai Zhu San (a traditional Chinese medicine formula), apply Hydrocortisone cream topically.
Treatment Group:On the basis of taking Shenling Baizhu San (a traditional Chinese medicine formula), apply Jiawei Qibai Powder topically.

Sponsors

The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for melasma according to both Western medicine and traditional Chinese medicine; (2) Be between the ages of 18 and 65 and can be either first-time sufferers or those with relapses; (3) Have not received any treatment related to melasma in the past four weeks; (4) Voluntarily participate in this study willing to cooperate with the entire treatment process and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with sensitive skin a history of photosensitivity or an allergy to the experimental medication components; (2) Patients with serious primary diseases such as cardiovascular and cerebrovascular diseases abnormal liver and kidney function hematological disorders severe mental illnesses and other pigmentary skin diseases of the face; (3) Pregnant women those planning to become pregnant and those who are breastfeeding; (4) Individuals with skin lesions on the facial area.

Design outcomes

Primary

MeasureTime frame
Melasma Area and Severity Index (MASI) score;

Secondary

MeasureTime frame
Hemoglobin Level;Skin Sebum Level;Melanin Level;Quality of Life Score for Melasma;Traditional Chinese Medicine Syndrome Observational Indicators.;TEWL;

Countries

china

Contacts

Public ContactYiling Chen

The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine

1016259101@qq.com15960385898

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026